| The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. | |
| | |
MedLine Citation:
|
PMID: 16724011 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Despite the availability of a variety of effective antihypertensive drugs, inadequate control of blood pressure is common in hypertensive patients. The aim of this study was investigate whether the alpha-adducin G460W polymorphism or angiotensinogen M235T polymorphism has an effect on the mean difference in blood pressure in subjects using antihypertensive drugs. Data from the Rotterdam Study, a population-based prospective cohort study in the Netherlands, was used. This study started in 1990 and included 7983 subjects of 55 years and older. Data from three examination rounds were used. Subjects were included when their blood pressure was elevated at 1 or more examinations and/or a diuretic, beta-blocker, calcium antagonist, or ACE inhibitor was used. A marginal generalized linear model was used to assess the drug-gene interaction. In total, 3025 hypertensives were included. No drug-gene interaction on blood pressure levels was found. The mean difference in systolic blood pressure (SBP) between subjects with the W-allele and GG genotype of the alpha-adducin gene was for diuretic users 1.25 mmHg (95% CI:-2.86 to 5.35), for beta-blockers 0.02 mmHg (95% CI:-3.39 to 3.42), for calcium antagonists -0.70 mmHg (95% CI:-5.61 to 4.21), and for ACE inhibitors -3.50 mmHg (95% CI:-9.02 to 2.02). The mean difference in SBP between subjects with the TT and MM genotype was for diuretic users -2.33 mmHg (95% CI:-8.32 to 3.66), for beta-blocker -0.06 mmHg (95% CI:-4.91 to 4.79), for calcium antagonist 0.59 mmHg (95% CI:-5.95 to 7.13), and for ACE inhibitor -2.33 mmHg (95% CI:-9.66 to 5.01). The G460W polymorphism and the M235T polymorphism did not modify the difference in blood pressure levels among subjects who used diuretics, beta-blockers, calcium antagonists, or ACE inhibitors. |
| | |
Authors:
|
Hedi Schelleman; Olaf H Klungel; Jacqueline C M Witteman; Albert Hofman; Cornelia M van Duijn; Anthonius de Boer; Bruno H C H Stricker |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-05-17 |
Journal Detail:
|
Title: European journal of human genetics : EJHG Volume: 14 ISSN: 1018-4813 ISO Abbreviation: Eur. J. Hum. Genet. Publication Date: 2006 Jul |
Date Detail:
|
Created Date: 2006-06-22 Completed Date: 2006-08-22 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9302235 Medline TA: Eur J Hum Genet Country: England |
Other Details:
|
Languages: eng Pagination: 860-6 Citation Subset: IM |
Affiliation:
|
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Aged Angiotensin-Converting Enzyme Inhibitors / therapeutic use Angiotensinogen / genetics* Antihypertensive Agents / therapeutic use* Calcium Channel Blockers / therapeutic use Calmodulin-Binding Proteins / genetics* Cohort Studies Diuretics / therapeutic use Female Humans Hypertension / drug therapy*, genetics Male Middle Aged Polymorphism, Genetic Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Calmodulin-Binding Proteins; 0/Diuretics; 0/adducin; 11002-13-4/Angiotensinogen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A locus for sacral/anorectal malformations maps to 6q25.3 in a 0.3 Mb interval region.
Next Document: Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpoly...